ArticleSeminars in arthritis and rheumatism2020

Long, relapsing, and atypical symptomatic course of COVID-19 in a B-cell-depleted patient after rituximab.

Jan Leipe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.